Ozempic 2 MG/dose (8 MG/3 ML) 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26F13DY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,332
Award facts
- Contract value 100% obligated
- $11,332.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,332.13 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml vials. This is a firm fixed-price contract with no set-aside designation, competitively awarded to the prime contractor. The delivery order is scheduled for completion by December 3, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement supporting military and veteran healthcare systems. The company's DLA Troop Support Medical prime contract functions as a comprehensive global pharmaceutical support vehicle, enabling the supply of an extensive range of medications, vaccines, and medical supplies to support Defense Health Agency and other government healthcare customers worldwide. Ozempic, a diabetes medication included in this delivery order, represents one of the specialty pharmaceutical products available under the broader contract vehicle that encompasses multiple therapeutic domains including neurological treatments, pain management medications, antibiotics, and specialized medical supplies.
Quick answers
Who was awarded contract SPE2DR26F13DY?
SPE2DR26F13DY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DR26F13DY worth?
The government has obligated $11,332 on SPE2DR26F13DY.
Is contract SPE2DR26F13DY an order under another contract?
Yes. SPE2DR26F13DY is a delivery order under SPE2DR25D1110, an indefinite delivery contract.
Was contract SPE2DR26F13DY competed?
The extent of competition for SPE2DR26F13DY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award